Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
UK Not Planning To Add to Regulatory Burden for Life Science Industry Post-Brexit
Mar 23 2017
•
By
Maureen Kenny
The UK MHRA says it will not be seeking to impose additional regulatory demands post-Brexit
More from Europe
More from Geography